Select Topics
Disorders
Cognition and Motivation
Systems Neuroscience
Molecular and Cellular
Neurotechnology

Genetic Engineering

Biological research often calls for imbuing cells, tissue, or animal models in the lab with specific new capabilities – or disabilities, for instance to observe the differences between altered and unaltered cells. Picower Institute neuroscientists employ advanced techniques such as CRISPR/Cas9, 3D stem cell and printing technologies, and transgenics to conduct such experiments.

Alzheimer's disease

Alzheimer’s disease and other dementias are neurodegenerative conditions characterized by a progressive loss of some mental functions, such as memory loss and cognitive decline. Through fundamental research on how the brain stores and recalls memory and on the biology of neurodegeneration, Picower researchers are developing crucial insights and working to translate them into potential therapies.

Down Syndrome

Down syndrome is the most common chromosomal disorder diagnosed in the U.S. and the leading cause of developmental disabilities worldwide. Picower research on the disorder includes creating stem cell lines and lab tissues, providing new insights into the molecular and cell biology of the disorder, and studying systems level interventions.

Mood Disorders

Mood disorders including depression and bipolar disorder are complex in how they affect emotion in the brain. Picower researchers investigate many aspects of these disorders including the circuits, regions and neuromodulators that are relevant in how they are manifested differently in disease.

Timely, far-reaching theta waves help organize cognition, study shows

November 9, 2026
Research Findings
When MIT neuroscientists measured brain cell activity and brain waves during a categorization game, they found that “theta” frequency waves dynamically sculpted multiple processes associated with cognition.

Mentees, colleagues, friends share remembrances of Susumu Tonegawa

October 26, 2026
Picower People
To remember Susumu Tonegawa, nearly 200 lab members and alumni, biology and neuroscience colleagues, and other well-wishers gathered with members of his family Oct. 16 in MIT Building 46 and online.

How the biggest Alzheimer’s risk gene disrupts the process of insulating neurons

October 15, 2026
Research Findings
With evidence from human cell cultures, post-mortem brain samples and mice, MIT researchers show that the APOE4 gene variant suppresses molecular signaling needed for oligodendrocytes to myelinate neurons. They also demonstrate a proof-of-concept fix.

Symposium highlights MIT’s wide range of innovations for aging brain health

September 30, 2026
Picower Events
In six talks Sept. 25, researchers from across MIT described projects aimed at advancing the understanding of and interventions against neurodegenerative diseases such as Alzheimer’s, Parkinson’s and ALS

Brain Biomarkers

September 29, 2026
Research Feature
Brain disorders are notoriously mysterious. To improve diagnosis and to better measure treatment efficacy, Picower Institute labs are developing objective and minimally invasive indicators of brain health.

How the brain keeps its options straight at decision time

September 9, 2026
Research Findings
Making a decision requires juggling a set of options without getting them confused or losing track of them. A new MIT study shows how ensembles of neurons encode information to maximize clarity throughout the process.

A burst of “pink noise” may lead to more restorative sleep

September 9, 2026
Research Findings
Delivered at just the right time, this type of auditory stimulus can strengthen the flow of cerebrospinal fluid, which clears debris from the brain and keeps it healthy.

Atlas of the brain’s striatum could guide researchers to new drug treatments

September 1, 2026
Research Findings
A new study reveals insights into populations of neurons affected by Huntington’s disease, schizophrenia, addiction, and other disorders.